An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Cue Health (Nasdaq: HLTH) will release its fourth quarter and full-year 2021 financial results on March 29, 2022. A conference call will follow at 1:30 p.m. PT to discuss these results and company highlights. Interested participants can join by calling (888) 708-0136 for domestic or (929) 517-9009 for international access, using conference ID: 2091976. The live webcast will also be available on their website. Cue Health aims to enhance health information accessibility and is noted for its FDA-authorized COVID-19 test.
Positive
Scheduled release of financial results may indicate confidence in performance.
First FDA-authorized at-home COVID-19 test demonstrates innovative capabilities.
Negative
None.
SAN DIEGO--(BUSINESS WIRE)-- Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its fourth quarter and full-year 2021 financial results on Tuesday, March 29, 2022. In conjunction with the release, Cue will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.
Interested parties may access the live call via telephone by dialing (888) 708-0136 for domestic callers or (929) 517-9009 for international callers, using conference ID: 2091976. The live webcast of the call may be accessed by visiting the “Events” section of the Company’s website at investors.cuehealth.com. A replay of the webcast will be available on the Company’s website shortly after the conclusion of the call.
About Cue Health Cue Health (Nasdaq: HLTH) is a healthcare technology company that makes it easy for individuals to access health information and places diagnostic information at the center of care. Cue Health enables people to manage their health through real-time, actionable, and connected health information, offering individuals and their healthcare providers easy access to lab-quality diagnostics anywhere, anytime, in a device that fits in the palm of the hand. Cue Health's first-of-its-kind COVID-19 test was the first FDA-authorized molecular diagnostic test for at-home and over-the-counter use without a prescription and physician supervision. Outside the United States, Cue Health has received the CE mark in the European Union, Interim Order authorization from Health Canada, regulatory approval from India'sCentral Drugs Standard Control Organization, and PSAR authorization from Singapore'sHealth Sciences Authority. Cue was founded in 2010 and is headquartered in San Diego. For more information, please visit www.cuehealth.com.
